ASTM E2882 - 12

    Standard Guide for Analysis of Clandestine Drug Laboratory Evidence

    Active Standard ASTM E2882 | Developed by Subcommittee: E30.01

    Book of Standards Volume: 14.02

      Format Pages Price  
    PDF 5 $48.00   ADD TO CART
    Hardcopy (shipping and handling) 5 $48.00   ADD TO CART

    Significance and Use

    4.1 An understanding of clandestine laboratory synthetic routes and the techniques used in the analysis of related samples is considered to be fundamental to the interpretation and reporting of results. This understanding assures that results and conclusions from methods are reliable and analytical schemes are fit for purpose.

    4.2 The qualitative and quantitative analyses of clandestine laboratory evidence can require different approaches relative to routine seized drug analyses. Analysts shall understand the limitations of the procedures used in their qualitative and quantitative analyses. These include such factors as method selectivity, uncertainty, and the basis for inferences from a sample(s) to a population.

    4.3 Laboratory management shall ensure that clandestine laboratory synthesis and analysis training be provided through relevant procedures, literature, and practical experience. Practical experience typically includes production, sampling and analysis of clandestine laboratory training samples.

    4.4 Laboratory management shall ensure that chemical safety and hygiene plans address and mitigate hazards associated with clandestine laboratory evidence.

    4.5 Laboratory management shall consider customer/local requirements which influence the application of these recommendations.

    1. Scope

    1.1 This guide is intended to be used in conjunction with the general requirements for the analysis of seized drugs (Practices E2326, E2327, E2329, and E2549; Guides E2548 and E2329). This guide provides guidance on the chemical analysis of items and samples related to suspected clandestine drug laboratories. It does not address scene attendance or scene processing. This document provides general guidance for the analysis of clandestine laboratory evidence and is not a substitute for detailed and validated laboratory policies and technical procedures.

    1.2 This guide does not replace knowledge, skill, ability, experience, education, or training and should be used in conjunction with professional judgment.

    2. Referenced Documents (purchase separately) The documents listed below are referenced within the subject standard but are not provided as part of the standard.

    ASTM Standards

    D6161 Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration and Reverse Osmosis Membrane Processes

    E1605 Terminology Relating to Lead in Buildings

    E2326 Practice for Education and Training of Seized-Drug Analysts

    E2327 Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis

    E2329 Practice for Identification of Seized Drugs

    E2363 Terminology Relating to Process Analytical Technology in the Pharmaceutical Industry

    E2548 Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis

    E2549 Practice for Validation of Seized-Drug Analytical Methods

    F2725 Guide for European Unions Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange

    ICS Code

    ICS Number Code 71.040.40 (Chemical analysis)

    Referencing This Standard
    Link Here
    Link to Active (This link will always route to the current Active version of the standard.)

    DOI: 10.1520/E2882-12

    Citation Format

    ASTM E2882-12, Standard Guide for Analysis of Clandestine Drug Laboratory Evidence, ASTM International, West Conshohocken, PA, 2012,

    Back to Top